Updates matching "Access to Biomarker Testing"

INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance plans in the Hoosier state. The following is a statement from

Cancer patients, survivors, their families and caregivers from throughout Washington gathered at the Capitol on Monday to ask legislators to support House Bill 1450, which would have expanded insurance coverage of biomarker testing and made sure as many state residents as possible have access to this technology. They were disappointed to learn that the bill did not advance through House Appropriations and so instead turned their efforts and advocacy to the 2025 session.

HARRISBURG, PA – FEBRUARY 5, 2024 – With the 2024 legislative session underway and Governor Shapiro’s budget address set for tomorrow, here is a statement from Donna Greco, American Cancer Society Cancer Action Network (ACS CAN) Pennsylvania Government Relations Director: “As Pennsylvania lawmakers return to the 2024 legislative session, ACS

Those who traveled to the Capitol will continue to work with legislators to change that and urge them to get biomarker access expanded in 2025. Eventual passage of this legislation will make sure more residents have insurance coverage that allows for easy access to precision medicine.

AUGUSTA, ME – JANUARY 29, 2024 – On Tuesday, January 30, Maine’s Joint Standing Committee on Health Coverage, Insurance and Financial Services will consider LD 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges Committee members to support the bill, which aims to expand coverage for biomarker testing—when

Indiana Must Do Better to Reduce the Burden of Cancer

ALBANY, NY – JANUARY 17, 2024 – With her budget address yesterday, the character of Governor Hochul’s 2024 legislative agenda comes into focus, leading advocates to react and highlight opportunities to reduce the cancer burden in New York in 2024. The following is a statement from the American Cancer Society

CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack

TRENTON, NJ – JANUARY 12, 2024 – As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on New Jerseyans, securing each resident equal opportunity to prevent, detect, treat and survive